Production (Stage)
Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.54% | -1.26% | 0.39% | 3.10% | 6.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.54% | -1.26% | 0.39% | 3.10% | 6.01% |
| Cost of Revenue | -1.43% | -1.15% | 0.04% | 0.91% | 2.33% |
| Gross Profit | -3.00% | -1.31% | 0.53% | 4.04% | 7.61% |
| SG&A Expenses | -3.26% | -1.54% | -3.76% | -2.07% | 1.64% |
| Depreciation & Amortization | -0.45% | 10.82% | 21.02% | 36.51% | 36.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.67% | -1.23% | -0.23% | 2.63% | 5.47% |
| Operating Income | 16.87% | 0.81% | 7.70% | 2.83% | 0.46% |
| Income Before Tax | -345.46% | -352.47% | 75.77% | 75.18% | 96.74% |
| Income Tax Expenses | -582.23% | 898.95% | 336.49% | 331.65% | 178.69% |
| Earnings from Continuing Operations | -334.44% | -354.35% | 75.47% | 74.97% | 96.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -334.44% | -354.35% | 75.47% | 74.97% | 96.70% |
| EBIT | 16.87% | 0.81% | 7.70% | 2.83% | 0.46% |
| EBITDA | -24.42% | -27.26% | 201.83% | 1,288.95% | 445.12% |
| EPS Basic | -322.06% | -338.55% | 76.58% | 76.07% | 96.78% |
| Normalized Basic EPS | 21.30% | 4.47% | 22.04% | 16.31% | 16.95% |
| EPS Diluted | -322.06% | -338.55% | 76.58% | 76.07% | 96.78% |
| Normalized Diluted EPS | 21.30% | 4.47% | 22.04% | 16.31% | 16.95% |
| Average Basic Shares Outstanding | 3.86% | 3.64% | 3.23% | 2.79% | 2.30% |
| Average Diluted Shares Outstanding | 3.86% | 3.64% | 3.23% | 2.79% | 2.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |